What is the appropriate next step in management for a patient with a six‑week persistent cough despite a short course of oral prednisone, intranasal fluticasone, a five‑day azithromycin course, and an albuterol inhaler prescribed two weeks ago?

Management of Six-Week Persistent Cough After Initial Treatment

At six weeks, this patient's cough has now transitioned to chronic cough (≥8 weeks is approaching), and you should immediately discontinue the Flonase, stop any further antibiotics, and initiate a systematic evaluation for the three most common causes: upper airway cough syndrome (postnasal drip), asthma, and gastroesophageal reflux disease 1.

Why Current Treatment Should Stop

The azithromycin (Z-pack) was inappropriate from the start—this was clearly a viral illness with negative chest X-ray and no bacterial features. Continuing antibiotics serves no purpose and only contributes to resistance. The intranasal fluticasone (Flonase) has minimal evidence for chronic cough management despite being widely recommended 2. A 2024 systematic review found zero eligible studies demonstrating INCS efficacy specifically for chronic cough, revealing a major disconnect between guideline recommendations and actual evidence 2.

Immediate Next Steps

1. Reassess for Red Flags

Before proceeding, confirm absence of:

• Hemoptysis
• Unintentional weight loss
• Fever or night sweats
• Progressive dyspnea
• Smoking history requiring further workup

2. Evaluate for the "Big Three" Causes

Upper Airway Cough Syndrome (UACS/Postnasal Drip):

• Look for: throat clearing, nasal discharge, sensation of postnasal drip, frequent throat clearing
• Trial: First-generation antihistamine (e.g., diphenhydramine or chlorpheniramine) PLUS decongestant (pseudoephedrine) 3
• Duration: 2-3 weeks minimum

Asthma/Cough-Variant Asthma:

• The albuterol inhaler you prescribed was reasonable, but insufficient
• Order pulmonary function testing with methacholine challenge—this is the preferred confirmatory test 3
• If positive or high clinical suspicion: Initiate inhaled corticosteroids (ICS), not systemic prednisone 4
• The 1992 study showing prednisone response is outdated; modern management uses ICS for maintenance 4

Gastroesophageal Reflux Disease:

• Ask about: heartburn, regurgitation, worse when lying down, sour taste
• However, do NOT empirically start a proton pump inhibitor without GERD symptoms or positive testing 5—the 2016 CHEST guidelines explicitly recommend against PPI therapy in unexplained chronic cough with negative GERD workup

3. Use a Validated Cough Assessment Tool

Document baseline severity using a validated instrument (Leicester Cough Questionnaire, Cough Severity Diary, or visual analog scale) to objectively track response to treatment 1. This is now a standard recommendation in the 2018 CHEST guidelines.

If Cough Persists Beyond 8 Weeks Despite Targeted Treatment

Once you've completed appropriate trials for UACS, asthma, and GERD (each requiring 2-4 weeks), and the cough persists, this becomes unexplained chronic cough (UCC) 5.

For Unexplained Chronic Cough:

First-line: Multimodality Speech Pathology Therapy

• This is the only intervention with Grade 2C recommendation for UCC 5
• Includes cough suppression techniques, breathing exercises, and counseling
• Shown to improve cough severity and quality of life

Second-line: Gabapentin

• Dosing: Start 300 mg once daily, escalate as tolerated up to 1,800 mg/day in two divided doses 5
• Discuss side effects upfront (dizziness, somnolence, peripheral edema)
• Reassess risk-benefit at 6 months before continuing 5
• Alternative: Pregabalin or amitriptyline 6

Common Pitfalls to Avoid

1. Don't continue antibiotics—there's no role for repeated antibiotic courses in chronic cough without evidence of bacterial infection
2. Don't continue systemic corticosteroids—the short prednisone course was reasonable initially, but prolonged use is inappropriate without a specific diagnosis
3. Don't use PPI empirically—only if GERD symptoms or positive testing present 5
4. Don't use ICS without evidence of bronchial hyperresponsiveness or eosinophilia 5

Practical Algorithm for This Patient

1. Stop Flonase and any further antibiotics immediately
2. Continue albuterol PRN while awaiting PFTs
3. Order pulmonary function tests with methacholine challenge
4. Start empiric trial for UACS: first-generation antihistamine + decongestant for 2-3 weeks
5. Implement validated cough severity assessment
6. Schedule follow-up in 4 weeks 1
7. If no improvement after addressing UACS and asthma: refer to speech pathology for cough suppression therapy and consider gabapentin trial

The key message to the patient: "We're transitioning from treating an acute infection to systematically evaluating the underlying cause of your persistent cough. The antibiotics and some of your current medications aren't helping and should be stopped. We need specific testing to identify what's driving your cough, starting with breathing tests and a trial of different medications targeting postnasal drip."